Gilead Sciences, Inc.

United States of America


 
Total IP 1,965
Total IP incl. subs 3,250 (+ 1,285 for subs)
Total IP Rank # 645
IP Activity Score 3.7/5.0    1,091
IP Activity Rank # 678
IP AS incl. subs 3.6/5.0    1,812
Stock Symbol
ISIN US3755581036
Market Cap. 114,800M  (USD)
Industry Drug Manufacturers - Major
Sector Healthcare
Dominant Nice Class Medical, veterinary, hygienic an...

Patents

Trademarks

834 143
281 52
573 25
57
 
Last Patent 2025 - Thieno[3,2-d]pyrimidine, furo[3,...
First Patent 1986 - 9-(phosponylmethoxyalkyl) adenin...
Last Trademark 2024 - GILEAD FOR GOOD
First Trademark 1989 - AMBISOME

Subsidiaries

13 subsidiaries with IP (133 patents, 1152 trademarks)

6 subsidiaries without IP

 Register for free to unlock the subsidiary list

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 G/S Promoting public awareness of environmental, social, and governance initiatives; business informa...
G/S Charitable foundation services, namely, providing financial assistance for programs and services ...
G/S Assisting patients in enrolling in pharmaceutical reimbursement programs of others
G/S Healthcare services; medical services; telemedicine services; providing medical information via a...
G/S Insurance information; insurance consultancy; providing counseling and consulting in the field of...
G/S Retail pharmacy services; online retail pharmacy services; pharmaceutical services, namely proces...
G/S Platform as a service featuring computer software platforms for requesting pharmacy products and ...
G/S Providing medical information regarding the prevention, treatment and diagnosis of HIV/AIDS
G/S providing grants to individuals, organizations, and programs in support of improving health and w...
Invention Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof. The pres...
Invention Parp7 inhibitors. Provided herein is a compound of Formula (I) or a pharmaceutically acceptable s...
Invention Parp7 inhibitors. Provided herein is a compound of Formula (I): or a pharmaceutically acceptable ...
Invention Methods of identifying hiv patients sensitive to therapy with gp120 v3 glycan-directed antibodies...
Invention Processes for making irak4 inhibitors. The present disclosure relates generally to processes for...
Invention Salts and solid forms of a compound that modulates irak4. The present disclosure relates to salt...
Invention Processes for making irak4 inhibitors. The present disclosure relates generally to processes for ...
Invention Salts and solid forms of a compound that modulates irak4. The present disclosure relates to salts...
Invention Hiv inhibitor compounds. The invention provides a compound of Formula I: The invention provide...
Invention Kras modulating compounds. Provided herein are compounds, and pharmaceutically acceptable salts ...
Invention Kras modulating compounds. Provided herein are compounds, and pharmaceutically acceptable salts t...
Invention Antiviral compounds. The present disclosure provides a compound of Formula I: The present disc...
Invention Mk2 inhibitors and methods of making and using the same. The present disclosure relates generally...
Invention Methods and intermediates for preparing antiviral prodrugs. The present invention is related to p...
Invention Solid forms of a nucleoside reverse transcriptase translocation inhibitor. Retroviridae Retroviri...
Invention Phospholipid compounds and methods of making and using the same. Phospholipid compounds and meth...
Invention Fxr (nr1h4) modulating compounds. The present disclosure relates generally to compounds that bin...
Invention Sars-cov2 main protease inhibitors. The present disclosure relates to compounds of Formula I: ...
Invention Quinoline derivatives. The present disclosure provides a compound of Formula (I): The present ...
Invention Therapeutic compounds for hiv. The present disclosure relates generally to certain compounds, ph...
Invention Process of preparing hiv capsid inhibitor. The present disclosure relates generally to processes...
Invention Solid forms. The present disclosure relates to solid forms of compounds and pharmaceutical compo...
Invention Solid forms of compounds useful in the treatment of hiv. RetroviridaeRetroviridae viral infection...
Invention Process of preparing hiv capsid inhibitor. RetroviridaeRetroviridae viral infection, including an...
Invention Quinazolinyl-indazole derivatives as therapeutic compounds for hiv. The present disclosure relate...
Invention Anti-hiv compounds. The invention provides compounds having Formula (I): or a pharmaceutically ac...
Invention Combination therapy for treatment of liver disease. The present disclosure relates to a method o...
Invention Prmt5 inhibitors and uses thereof. The present disclosure relates generally to compounds that in...
G/S Providing online, non-downloadable interactive chatbot software for providing medical information...
Invention Methods of preparing 1'-cyano nucleosides. The present disclosure generally describes methods of...
Invention Compounds and methods for treatment of viral infections. The present disclosure provides compoun...
Invention Diacylglycerol kinase modulating compounds. The present disclosure provides diacylglycerol kinas...
Invention 4-aminopyrrolo[2,1-f][1,2,4]triazine c-nucleoside compounds and methods for treatment of viral in...
Invention Prmt5 inhibitors and uses thereof. The present disclosure relates generally to compounds that inh...
Invention Dosing regimen of capsid inhibitor. The present disclosure relates to dosing regimens of an HIV ...
Invention Dosing regimen of capsid inhibitor. The present disclosure relates to dosing regimens of an HIV c...
Invention Therapeutic compounds. The present disclosure relates to a compound of formula (Ia), (Ib), (IIa)...
Invention Substituted pyrrolo[1,2-b]pyridazines as bifunctional degraders of interleukin-1 receptor-associa...
Invention Process for preparing bulevirtide. The present application provides process for preparing an acet...
Invention Crystalline forms of an azetidine parp1 inhibitor. Described herein are crystalline forms of 5-((...
Invention Crystalline forms of an azetidine parp1 inhibitor. Described herein are crystalline forms of 5-(...
Invention Thieno[3,2-d]pyrimidine, furo[3,2-d]pyrimidine, and pyrrolo[3,2-d]pyrimidines useful for treating...
G/S Pharmaceutical preparations.
Invention Capsid inhibitors for the treatment of hiv. The present disclosure relates to compounds of Formu...
G/S Providing online non-downloadable interactive chatbot software for providing medical information....
Invention Compounds and methods for treatment of viral infections. Compounds and methods of using said com...
2023 Invention Substituted pyridotriazine compounds and uses thereof. The present disclosure relates generally t...
G/S Providing online non-downloadable interactive chatbot software for providing medical information ...
G/S Charitable services, namely, providing financial grants to individuals, organizations and program...
Invention Modulators of toll-like receptors for the treatment of hiv. Provided are methods, uses, pharmace...
G/S Downloadable podcasts in the field of healthcare, medical conditions and cancer treatment Providi...
G/S Promoting public awareness in the field of oncology, namely, medical and scientific research, tre...
G/S downloadable computer software in the nature of mobile applications for tracking events and educa...
Invention Weekly regimen of lenacapavir for the treatment and prevention of hiv. The present disclosure pro...
G/S Downloadable podcasts in the field of healthcare, medicine, public health, infectious diseases, a...
G/S Promoting public awareness about treatments and diagnosis in the field of oncology. Museum servic...
G/S Providing an internet website portal featuring technology that enables users to submit research g...
G/S Providing an internet website portal featuring technology that enables users to submit research ...
G/S Providing financial information regarding assistance with patient access to HIV treatment program...
G/S Educational services, namely events and seminars, in the field of oncology Providing medical info...
G/S Pharmaceutical products. Medical devices; surgical, medical, dental and veterinary apparatus and ...
2022 G/S Providing grants to individuals, organizations and programs in the field of oncology
G/S charitable services, namely, providing financial grants to individuals, organizations and program...
G/S Condoms
G/S Conducting programs, conferences, courses, tutorials and seminars regarding prevention, treatment...
G/S Conducting educational events, course, tutorials and seminars regarding prevention, treatment an...
G/S Promoting public awareness of medical treatment guidelines, clinical trial results, and disease p...
G/S Arranging and conducting of conferences, congresses and symposiums in the field of hiv; education...
G/S Education relating to pharmaceuticals, medical conditions, and medical treatments; providing of t...
G/S Providing medical information regarding diagnosis and treatment in the field of breast cancer; Pr...
G/S promoting public awareness of testing, diagnosis, prevention, and treatment of HIV and AIDS
2021 G/S Conducting educational seminars in the field of infectious diseases and dissemination of material...
G/S Providing grants for research, education and innovation in the field of HIV
G/S Promoting public awareness of testing, diagnosis, prevention, and treatment of HIV and AIDS
G/S charitable services, namely, providing financial grants for to individuals, organizations and pro...
G/S providing grants to individuals, organizations and programs in support of improving health and we...
G/S Pharmaceutical preparations; Pharmaceutical preparations, namely, pharmaceuticals for the treatme...
G/S Pharmaceutical and veterinary preparations; pharmaceuticals for the treatment of fungal infectio...